Biotest Italia S.R.L.

Biotest Italia S.R.L. company information, Employees & Contact Information

Biotest Italia Srl è l’affiliata italiana di Biotest AG, azienda di Dreieich (Germania). E’ presente nei principali paesi europei, Asia e America Latina ed occupa circa 2.000 persone che ogni giorno ricercano, producono e distribuiscono farmaci cosiddetti plasma derivati. I plasma derivati sono farmaci biologici derivati, appunto, dal plasma umano , la componente liquida di colore giallo paglierino del sangue, che rimane dopo che i globuli rossi, i globuli bianchi e le piastrine sono stati rimossi dai processi di lavorazione. I plasma derivati, solo apparentemente, sembrano farmaci come tutti gli altri, ma in realtà sono molto particolari perché ottenuti da questa materia prima preziosa e unica perché rappresenta un bene comune ed essenziale che, ad oggi, si ottiene unicamente grazie alla donazione di sangue. Il bene di tutti deriva da ognuno! Dopo la raccolta il plasma viene lavorato da Biotest in uno dei più moderni impianti d’Europa e del mondo, fino ad ottenere farmaci efficaci e purissimi. Questi farmaci trovano impiego nella terapia di malattie pericolose per la vita, come disturbi della coagulazione (emofilia), gravi infezioni e alterazioni del sistema immunitario. I prodotti Biotest soddisfano gli standard più elevati e sono commercializzati in mercati che presentano i più rigidi requisiti di approvazione. La vita di molte persone che soffrono di gravi malattie rare dipende dalla disponibilità di terapie con farmaci plasma derivati e, per fortuna, la natura ha “messo in circolo” questo bene prezioso in ognuno di noi, il sangue. Un bene oggi facile da condividere e da cui possono nascere nuove speranze, nuove opportunità, nuove prospettive, grazie all’impegno di un circolo virtuoso di professionisti. E’ l’origine del nostro posizionamento, From Nature For Life: perché dalla natura, da una sua materia prima, sviluppiamo farmaci in grado di salvare vite.

Company Details

Employees
16
Founded
-
Address
Via Leonardo Da Vinci, 43, Trezzano Sul Naviglio,milano 20090,italy
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Trezzano Sul Naviglio, Milano
Looking for a particular Biotest Italia S.R.L. employee's phone or email?

Biotest Italia S.r.l. Questions

News

UCLA receives $2 million for dementia, osteoporosis research from founders of Biotest - UCLA

UCLA receives $2 million for dementia, osteoporosis research from founders of Biotest UCLA

Grifols Completes Acquisition of Biotest Shares Following Delisting - TipRanks

Grifols Completes Acquisition of Biotest Shares Following Delisting TipRanks

Ashurst advises Biotest on the public delisting offer by GRIFOLS and its delisting from the Frankfurt Stock Exchange - Ashurst

Ashurst advises Biotest on the public delisting offer by GRIFOLS and its delisting from the Frankfurt Stock Exchange Ashurst

Osborne Clarke advises Grifols on delisting offer and delisting from stock exchange of Biotest - Osborne Clarke

Osborne Clarke advises Grifols on delisting offer and delisting from stock exchange of Biotest Osborne Clarke

Grifols to make €350-million takeover bid for Biotest capital it does not yet control, with aim of delisting it - The Corner .eu

Grifols to make €350-million takeover bid for Biotest capital it does not yet control, with aim of delisting it The Corner .eu

The Biotest Lake – a unique place for both sea eagles and climate researchers - group.vattenfall.com

The Biotest Lake – a unique place for both sea eagles and climate researchers group.vattenfall.com

Grifols Receives Approval for Biotest Acquisition Offer - TipRanks

Grifols Receives Approval for Biotest Acquisition Offer TipRanks

Grifols launches a €350 million takeover bid for its subsidiary Biotest. - Diari ARA

Grifols launches a €350 million takeover bid for its subsidiary Biotest. Diari ARA

Grifols' takeover bid for Biotest, accepted by 2.11% of ordinary shares with voting rights (1.05% of capital) - The Corner .eu

Grifols' takeover bid for Biotest, accepted by 2.11% of ordinary shares with voting rights (1.05% of capital) The Corner .eu

Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US - PR Newswire

Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US PR Newswire

Biotest wins FDA approval for plasma protein therapy - Pharmaceutical Technology

Biotest wins FDA approval for plasma protein therapy Pharmaceutical Technology

The firms prepping Grifols' Biotest offer - Reuters

The firms prepping Grifols' Biotest offer Reuters

Comparing ecotoxicological and physicochemical indicators of municipal wastewater effluent and river water quality in a Baltic Sea catchment in Poland - ScienceDirect.com

Comparing ecotoxicological and physicochemical indicators of municipal wastewater effluent and river water quality in a Baltic Sea catchment in Poland ScienceDirect.com

Creat Explores Options for German Blood Plasma Firm Biotest - Bloomberg.com

Creat Explores Options for German Blood Plasma Firm Biotest Bloomberg.com

German stock market supervisor approves Grifols' takeover bid for subsidiary Biotest at €43 per share - The Corner .eu

German stock market supervisor approves Grifols' takeover bid for subsidiary Biotest at €43 per share The Corner .eu

BionorthTX Names Pharma Entrepreneur, Investor, and Philanthropist as Stone Award Recipient - Dallas Innovates

BionorthTX Names Pharma Entrepreneur, Investor, and Philanthropist as Stone Award Recipient Dallas Innovates

Suspect identified in fatal Augusta stabbing at Biotest Plasma Center - WJBF

Suspect identified in fatal Augusta stabbing at Biotest Plasma Center WJBF

Spain's Grifols to buy rival Biotest for up to $1.9 bln - Reuters

Spain's Grifols to buy rival Biotest for up to $1.9 bln Reuters

Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes - Bloomberg.com

Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes Bloomberg.com

Osborne Clarke advises Grifols on EUR1.1bn Biotest acquisition - Osborne Clarke

Osborne Clarke advises Grifols on EUR1.1bn Biotest acquisition Osborne Clarke

February: KWS Biotest | News and features - University of Bristol

February: KWS Biotest | News and features University of Bristol

Alpha Pharma signs MoU with Biotest to produce Plasma derived medicines in KSA - ZAWYA

Alpha Pharma signs MoU with Biotest to produce Plasma derived medicines in KSA ZAWYA

Ha-Ha! Biotest Sells a Beauty Product! - t-nation.com

Ha-Ha! Biotest Sells a Beauty Product! t-nation.com

Top Biotest Italia S.R.L. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant